Chemoinformaics analysis of (10E,12Z,15Z)-9-OXO-10,12,15-OCTADECATRIENOIC-ACID
| Molecular Weight | 292.419 | nRot | 13 |
| Heavy Atom Molecular Weight | 264.195 | nRig | 5 |
| Exact Molecular Weight | 292.204 | nRing | 0 |
| Solubility: LogS | -3.245 | nHRing | 0 |
| Solubility: LogP | 3.866 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 51.1362 |
| nHD | 1 | BPOL | 29.8258 |
| QED | 0.39 |
| Synth | 2.802 |
| Natural Product Likeliness | 1.484 |
| NR-PPAR-gamma | 0.524 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.018 |
| Pgp-sub | 0.005 |
| HIA | 0.013 |
| CACO-2 | -4.835 |
| MDCK | 0.0000237 |
| BBB | 0.287 |
| PPB | 0.968542 |
| VDSS | 0.327 |
| FU | 0.0226959 |
| CYP1A2-inh | 0.027 |
| CYP1A2-sub | 0.397 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.152 |
| CYP2c9-inh | 0.037 |
| CYP2c9-sub | 0.977 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.713 |
| CYP3a4-inh | 0.024 |
| CYP3a4-sub | 0.069 |
| CL | 1.253 |
| T12 | 0.911 |
| hERG | 0.143 |
| Ames | 0.417 |
| ROA | 0.464 |
| SkinSen | 0.963 |
| Carcinogencity | 0.647 |
| EI | 0.311 |
| Respiratory | 0.933 |
| NR-Aromatase | 0.092 |
| Antiviral | Yes |
| Prediction | 0.572922 |